Aspen shares dip 8% a er forecast

Shares in Aspen Pharmacare fell more than 8% in early trade yesterday, a day after it forecast full-year revenue growth of between 1% and 4% in commercial pharmaceuticals.

The drugmaker said in a statement that weaker performance across Europe had offset the positive performance for commercial pharmaceuticals in most emerging markets. – Reuters